Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence

September 7, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

Post navigation

← Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up Gravel Ridge Farms Recalls Cage Free Egg Due to Possible Salmonella Contamination →
Proudly powered by WordPress